RealTalk MS

Conversations about MS almost always get around to the high cost of MS disease-modifying therapies. Joining me on the podcast is the CEO of Genentech, Alexander Hardy. Genentech is a biotech company that many of you know as the manufacturer of Ocrevus, the first approved disease-modifying therapy that treats both relapsing-remitting MS and primary progressive MS. During our wide-ranging conversation, Alexander and I get into the cost of MS prescription medications, the real costs of bringing a new drug to market, racial disparities in clinical trials, inequities in our healthcare system, and more. It's a conversation that you won't want to miss. We'll also tell you where you can get a FREE copy of Dr. Brandon Beaber's book, Resilience in the Face of Multiple Sclerosis, and where to sign up for the next series of Virtual Jumpstart programs from CAN-DO MS. We'll even share the details about this Sunday's Longest Day of Golf, a creative (and very successful!) DIY fundraising event for the National MS Society. We're also talking about a newly published study that shows that most relapsing-remitting MS disability accumulation is progressive and not tied to relapses. And we'll tell you about another study that shows that most people living with MS want to discuss the cost of their treatment with their neurologist, but very few do. We'll even share our thoughts about how we can begin to fix this. We have a lot to talk about! Are you ready for RealTalk MS??!

It's Our 150th Episode! :22

Get in Touch with RealTalk MS 1:36

Get Your Free Copy of Resilience in the Face of Multiple Sclerosis 3:34

CAN-DO MS Virtual Jumpstart Programs 4:43

The Longest Day of Golf Fundraising Event for the National MS Society 5:38

Study Finds Most Relapsing-Remitting MS Disability Accumulation Is Progressive and Not Tied to Relapses 7:29

Survey Shows Most MS Patients Want to Discuss the Cost of MS Care...But Don't 9:50

"Patients" are Customers! 11:31

My Interview with Alexander Hardy 13:09

Share this episode 29:31

Please Support the National MS Society COVID-19 Response Fund 29:50

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/150

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected]Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

To receive a free copy of Resilience in the Face of Multiple Sclerosis, just jump onto Twitter, and request your copy by sending a Tweet to the author, @Brandon_Beaber.

CAN-DO MS Virtual Jumpstart Programs

Longest Day of Golf Fundraising Event for the National MS Society

STUDY: Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

STUDY: Perceptions and Experiences of Multiple Sclerosis Patients Regarding Out-of-Pocket Costs of Care Discussions

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 150 Hosted By: Jon Strum Guests: Alexander Hardy

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, Genentech, Ocrevus, Resilience, RealTalkMS

Privacy Policy

The International Progressive MS Alliance is about to publish a paper that recommends advancing research on a specific biomarker to predict MS progression, and we're getting a pre-publication preview of what that paper is all about. My guests are Dr. Robert Fox, a neurologist and Vice-Chair for Research at the Cleveland Clinic Neurological Institute, and Caroline Sincock, who lives with progressive MS. Both Doctor Fox and Caroline are members of the International Progressive MS Alliance Scientific Steering Committee and are among the authors of the new paper that we're going to preview. We're also talking about the results of a study that show how increasing the energy in cells damaged by demyelination may stop MS progression. We'll tell you why Mayzent failed to gain approval to treat active secondary progressive MS in England. We'll introduce you to the winner of the first Novartis Innovation Prize for Assistive Tech for Multiple Sclerosis. And we'll discuss study results that show that a protein in the blood called neurofilament light chain may predict MS progression. We have a lot to talk about! Are you ready for RealTalk MS??!

The 2020 ACTRIMS-ECTRIMS Virtual Conference 3:10

Boosting cellular energy at sites of myelin loss may stop MS progression 4:18

Why NICE failed to approve Mayzent to treat active secondary progressive MS 6:29

Novartis Innovation Prize awarded to AccessNow 9:04

Elevated neurofilament light chain may predict risk of MS progression 10:02

My Interview with Dr. Robert Fox and Caroline Sincock 11:27

Share this episode 42:11

Please Support the National MS Society COVID-19 Response Fund 42:30

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/149

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected]Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

International Progressive MS Alliance

STUDY: Enhanced Axonal Response of Mitochondria to Demyelination Offers Neuroprotection: Implications for Multiple Sclerosis

AccessNow

STUDY: Plasma Neurofilament Light Levels are Associated with Risk of Disability in Multiple Sclerosis

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 149 Hosted By: Jon Strum Guests: Dr. Robert Fox and Caroline Sincock

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

The guidance for using MS disease-modifying therapies during the COVID-19 pandemic has been updated. My guest is Dr. Aaron Miller, the Chair of the National MS Society's National Medical Advisory Committee, the Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, and a Professor of Neurology at the Icahn School of Medicine at Mount Sinai, and we're talking about the new guidance for each and every MS disease-modifying therapy that's currently available. Last week, in the middle of the night, protections for people with pre-existing health conditions came under attack. We'll let you know what it all means and what's at stake for every person in the U.S. living with MS. We're also talking about the results of a study that show more people than ever are exploring alternative medicine in managing their MS symptoms. And we'll tell you about a new online MS Treatment Adherence Resource Center. In last week's International Progressive MS Alliance global webcast, 3 top MS experts shared very encouraging news about the development of new life-changing treatments for progressive MS. We'll let you know where to find the video replay of the webcast. And while you're checking online video replays, we'll let you know where you can find a replay of the Consortium of Multiple Sclerosis Centers' virtual Patient Education Program. We have a lot to talk about! Are you ready for RealTalk MS??!

In a late-night brief, the Trump administration asks the Supreme Court to invalidate Obamacare and eliminate protections for people with pre-existing health conditions 1:24

Catch the video replay of the International Progressive MS Alliance global webcast 6:04

Catch the video replay of the CMSC Patient Education Program 7:34

Survey says...Alternative medicine is widespread among people living with MS 8:19

MS Treatment Adherence Resource Center is launched 11:03

My Interview with Dr. Aaron Miller 13:06

Share this episode 23:26

Please Support the National MS Society COVID-19 Response Fund 23:45

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/148

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected]Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

Video Replay: International Progressive MS Alliance Webcast

Video Replay: Consortium of MS Centers Patient Education Program

STUDY: Cross-Sectional Survey of Complementary and Alternative Medicine Used in Oregon and Southwest Washington to Treat Multiple Sclerosis: A 17-Year Update

MS Treatment Adherence Resource Center

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 148 Hosted By: Jon Strum Guests: Dr. Aaron Miller

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, COVID19, RealTalkMS

Privacy Policy

Integrative medicine combines evidence-based alternative medicine with conventional medicine. My guest is Dr. Allen Bowling, an internationally renowned neurologist who specializes in integrative medicine for MS. When it comes to care and treatment for MS, Dr. Bowling has published over 100 articles in clinical and basic science journals. He's been involved in research related to nutrition, dietary supplements, and other non-pharmacologic therapies for the past 30 years. And our conversation covers CBD and other cannabis products as potential treatments for MS symptoms, we'll talk about diet and exercise, over the counter supplements, maintaining your emotional health, and lots more. An international committee of distinguished experts has just issued an important clarification in the terminology used to describe the status of a person with MS (including "active" secondary progressive, "worsening", and "progression"). We'll tell you all about this clarification and explain how it affects everything from recruiting for clinical trials to providing access to current MS disease-modifying therapies. We're also talking about a new Cleveland Clinic study that shows that neurological function deteriorates more quickly in depressed MS patients. We'll tell you about a study that underscores the importance of screening and treating people living with MS for anxiety along with depression. And you'll hear about a new web-based tool designed to help manage your emotional wellness. We have a lot to talk about! Are you ready for RealTalk MS??!

Expert panel clarifies terms used in describing MS disease status 2:33

COVID-19 in people with MS being treated with Ocrevus 7:45

Study shows neurological function deteriorates quicker in depressed MS patients 10:44

Anxiety & Depression in MS -- Study measures impact on quality of life 13:34

MS Trust & Biogen launch ACT MySelf web-based emotional wellness tool 16:06

My Interview with Dr. Allen Bowling 19:19

Share this episode 43:18

Please Support the National MS Society COVID-19 Response Fund 43:41

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/146

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected] Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

Dr. Allen Bowling: Neurology Care

The 2013 Clinical Course Descriptors for Multiple Sclerosis: A Clarification

COVID-19 in Persons with Multiple Sclerosis Treated with Ocrelizumab -- A Pharmacovigilance Case Series

STUDY: Depression in MS is Associated with Worsening Neuroperformance, Relapses, and New Brain Lesions

STUDY: Anxiety and Depression in Multiple Sclerosis (MS): Antecedents, Consequences, and Differential Impact on Well-Being and Quality of Life

ACT MySelf

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 146 Hosted By: Jon Strum Guests: Dr. Allen C. Bowling

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

Over the past several weeks, the United States has been forced to re-visit, re-examine, and reconsider its own history of racial inequality. This difficult but necessary national conversation has been driven by instances of racial injustice that have their origins in much broader systemic or institutional racism. Our conversations on RealTalk MS typically focus on multiple sclerosis research and multiple sclerosis care. So how does the subject of racial inequality find its way onto today's episode?

My guest is Dr. Jackie Bhattarai, a clinical psychologist and Assistant Professor of Physical Medicine and Rehabilitation at Johns Hopkins School of Medicine. Dr. Bhattarai's research is focused on identifying and understanding the causes of racial disparities in multiple sclerosis care. I think you'll find our conversation thought-provoking, maybe surprising and, I hope, concerning. We're also inviting you to this week's International Progressive MS Alliance global webcast when an international panel of MS experts will share the progress being made to speed the development of life-changing treatments for progressive MS. Our experts will also update us on the experiences of people living with MS who have contracted COVID-19, and how people with MS can minimize their risks during the pandemic. We'll tell you about a new National Institutes of Health grant aimed at determining the reliability of a proposed biomarker for MS. And we'll share the sobering results of a new study about MS and depression. We have a lot to talk about! Are you ready for RealTalk MS??!

Don't miss the International Progressive MS Alliance Webcast 1:30

Cleveland Clinic receives NIH grant to study MS diagnostic biomarker 3:58

Depression is 2-3 times more likely in MS patients 6:23

My Interview with Dr. Jackie Bhattarai 9:21

Share this episode 26:35

Please Support the National MS Society COVID-19 Response Fund 26:54

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/147

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected]Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

International Progressive MS Alliance Webcast Registration

STUDY: Incident Depression in Patients Diagnosed with Multiple Sclerosis: A Multi-Database Study

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 147 Hosted By: Jon Strum Guests: Dr. Jackie Bhattarai

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

MS changes as we age and it follows that managing MS should change, too. We're talking about managing MS through different stages of life with Dr. Jennifer Graves, an associate professor of neuroscience at UC San Diego Health, Director of the UC San Diego Neuroimmunology Research Program, and the Director of the Rady Children's Hospital Pediatric MS Clinic.

There's also lots of news to share about MS disease-modifying therapies including the availability of a newly-approved DMT, an extended FDA review of a potential DMT that was expected to be approved this month, encouraging news about yet another potential DMT that's currently in development, and a change in an already-approved DMT.

We have a lot to talk about! Are you ready for RealTalk MS??!

An important message from National MS Society President & CEO, Cyndi Zagieboylo :21

Did you catch our special bonus episode recapping the Consortium of MS Centers Annual Meeting? 2:32

Zeposia, a new MS disease-modifying therapy is now available in the U.S. 4:33

FDA Extends its review of Ofatumumab 5:51

EMD Serono Shares Encouraging Data from its Phase 2 Clinical Trial of Evobrutinib 6:59

EMA Approves Shorter Infusion Time for Ocrevus 7:52

My Interview with Dr. Jennifer Graves 9:07

Share this episode 25:26

Please Support the National MS Society COVID-19 Response Fund 25:50

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/145

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected] Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

Special Episode: CMSC 2020 Annual Meeting Recap

Zeposia Patient Information

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 145 Hosted By: Jon Strum Guests: Dr. Jennifer Graves

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

Don't miss our recap of the Consortium of Multiple Sclerosis Centers Annual Meeting with Internationally Certified MS Nurse, Cherie Binns. We're talking about aging with MS, managing mood and depression, the latest information on diet and exercise, and more.

We have a lot to talk about! Are you ready for RealTalk MS??!

My guest this week is Dr. Amy Sullivan, a Clinical Health Psychologist and the Director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic. We're talking about fighting feelings of isolation, building resiliency, caregiver emotional wellness, and how we should be thinking about living in a "new normal" world.

Massachusetts General Hospital and iConquer MS surveyed more than 1,000 people living with MS about the impact of the COVID-19 pandemic on their daily lives. We're among the first to hear the survey results from investigator Dr. Farrah Mateen and Hollie Schmidt.

MS research is about to take a quantum leap forward. We're talking about how the MULTI-ACT patient engagement roadmap will change the face of MS research and involve people affected by MS in ways that they've never been involved in research before.

And we'll share new data from an ongoing clinical trial that's evaluating a cutting-edge cell therapy designed to eliminate B-cells carrying the Epstein-Barr virus. (Many experts believe that eliminating the Epstein-Barr virus Barr virus might eliminate most multiple sclerosis.)

We have a lot to talk about! Are you ready for RealTalk MS??!

The International Progressive MS Alliance is partnering with MULTI-ACT -- and why that's a major step forward in MS research 2:26

New Data About ATA 188 Cell Therapy Clinical Trial Shared at the European Academy of Neurology Virtual Meeting 5:47

Dr. Farrah Mateen & Holly Schmidt Share Results from the Massachusetts General Hospital/iConquer MS COVID-19 Survey 10:08

My Interview with Dr. Amy Sullivan 30:21

Share this episode 41:27

Please Support the National MS Society COVID-19 Response Fund 41:50

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/144

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected] Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

International Progressive MS Alliance Announces Partnership with MULTI-ACT As Part of World MS Day Celebrations

MULTI-ACT Phase 1 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects with Progressive Multiple Sclerosis

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating & Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 144 Hosted By: Jon Strum Guests: Dr. Amy Sullivan, Dr. Farrah Mateen, Hollie Schmidt

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, Coronavirus, COVID19, iConquerMS, RealTalkMS

Privacy Policy

My guest is Dr. Ellen Mowry, a Professor of Neurology at Johns Hopkins University, where she also serves as the Director of the MS Experimental Therapeutics Program. Dr. Mowry has devoted her entire career to MS research, and her past research has led to breakthroughs in our understanding of MS. Today, Dr. Mowry is the co-principal investigator of an important research study whose outcome could have an impact on the treatment strategy for everyone diagnosed with MS.

We're also talking about World MS Day festivities. A major MS conference has gone virtual this week. We'll tell you how you can attend for free! And you'll learn about some outstanding new online resources -- webinars, presentations, and videos that you can access while you're at home.

We have a lot to talk about! Are you ready for RealTalk MS??!

Don't Miss These World MS Day Festivities 2:57

How You Can Attend a Free MS Conference 5:10

How You Can Attend a Free MS Patient Day Program 6:24

Catch All the Ask An MS Expert Video Replays 7:22

Catch All of the National MS Society's Exercise Videos 8:15

Register for these Can-Do MS Monthly Webinars 8:45

My Interview with Dr. Ellen Mowry 10:32

Share this episode 31:32

The National MS Society COVID-19 Response Fund 32:03

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/143

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected] Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

The TREAT-MS Clinical Trial for MS Patients

World MS Day Tune In For MS Website Registration World MS Day Tune In For MS Facebook Registration 2020 Consortium of MS Centers Virtual Annual Meeting Registration 2020 CMSC Virtual Patients Day Meeting Registration National MS Society Video: Aerobic Exercise Tips for MS National MS Society Video: Stretching Tips for MS National MS Society Video: Breathing Tips for MS Can-Do MS Webinar Series Registration

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating & Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 143 Hosted By: Jon Strum Guests: Dr. Ellen Mowry

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, Coronavirus, COVID19, RealTalkMS

Privacy Policy

MS research has reached an important moment. My guest, Dr. Bruce Bebo, calls it "an inflection point." Dr. Bebo is the Executive Vice-President of Research for the National MS Society, and we're talking with Bruce about the MS research projects that have him most excited, why now is the time to write the final chapter in solving the riddle of MS, and how we might even go about preventing people from developing MS.

We'll also give you all the details about the MS Society's newly published recommendations for exercise and physical activity for everyone living with MS. And we'll share the new question that you should be asking your neurologist at your next appointment.

We'll tell you about this year's recipient of the Dystel Prize for MS research. And you'll hear about a study that looked at the experiences of African-American women with MS.

We have a lot to talk about! Are you ready for RealTalk MS??!

National MS Society Publishes Exercise Recommendations for Everyone Living with MS 1:00

Dystel Prize for MS Research Awarded to Dr. Ian Duncan 5:11

The Experiences of African-American Women with MS 6:12

My Interview with Dr. Bruce Bebo 10:07

Share this episode 28:35

The National MS Society COVID-19 Response Fund 29:08

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/142

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected] Phone: (310) 526-2283

And don't forget to join us on the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

Exercise and Lifestyle Physical Activity Recommendations for People with Multiple Sclerosis Throughout the Disease Course

The Experience of African-American Women with Multiple Sclerosis

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating & Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 142 Hosted By: Jon Strum Guests: Dr. Bruce Bebo

Tags: MS, MultipleSclerosis, MSResearch, MSActivist, MSSociety, Interferon, Betaseron, Ocrevus, Coronavirus, COVID19, RealTalkMS

Privacy Policy